Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Other 1

Conditions

Endometrial Neoplasms 6Overweight 2Obesity 2Neoplasms 2Endometrial Hyperplasia 2Infertility 1Hematologic Neoplasms 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Breast Neoplasms 1Anorexia 1

Interventions

Tirzepatide 2Progestins 2Megestrol Acetate 2semaglutide 1Resistance Training 1Pterocarpus marsupium 1Nutrition Assessment 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Hysteroscopy 1Estrogen Replacement Therapy 1Blood Specimen Collection 13,5-dimethoxy-4'-hydroxystilbene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Endometrial Hyperplasia × Megestrol Acetate × 90 days × Clear all
NCT03671811 2026-06-03

Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy

City of Hope Medical Center

Phase 2 Active not recruiting
44 enrolled 12 charts
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡